OPR - Delayed Quote • USD GBIO May 2024 7.500 call (GBIO240517C00007500) Follow 0.4500 0.0000 (0.00%) At close: April 1 at 12:27 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for GBIO240517C00007500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: GBIO Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results Generation Bio to Present at the 2024 TD Cowen Health Care Conference Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference Charles Rowland Bought 179% More Shares In Generation Bio Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO) Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results